“Musculoskeletal research requires more than a standard CRO approach. At NBCD, we specialize in osteoarthritis and related conditions, using proprietary imaging, optimized trial designs, and decades of expertise to generate reliable, publication-ready data. Our focus means we anticipate challenges before they arise and keep trials running smoothly.”
Casper Clemmensen, Chief Commercial Officer
NBCD has acquired more than 20 years’ extensive experience with clinical trials in musculoskeletal and related disorders. The foundation for NBCD was laid back in 1989 by one of the pioneering forces in Danish biotech; Dr. Claus Christiansen.
Through the years, we have gained extensive experience with clinical trials in musculoskeletal indications, and today, we are recognized as a leader in the field – both scientifically and operationally.
By focusing solely on musculoskeletal disorders, we seek to provide our sponsors with expert knowledge in a complex field that generalist CROs cannot match.
At NBCD, we are highly specialized in clinical trials within musculoskeletal disorders – in fact, we are the world-leading clinical CRO within the OA field.
Our people have decades of experience in musculoskeletal disorders bringing deep scientific and operational expertise to every study.
NBCD has conducted numerous global osteoarthritis studies, contributing to new treatment developments and regulatory approvals through high-quality clinical research.
Musculoskeletal indications require specialized clinical trial designs to address complex joint, muscle and bone remodelling and degeneration, pain management, and variability in patient outcomes. At Sanos and NBCD, we bring decades of expertise in musculoskeletal clinical research, ensuring high-quality trial execution and regulatory success across phases.
We focus on osteoarthritis, osteoporosis, rheumatoid arthritis, and other joint and bone disorders, with a deep understanding of disease mechanisms that informs every stage of trial design and execution. We are also bridging musculoskeletal clinical research with obesity and metabolic diseases – integrating expertise from both areas to ensure the development of treatments that address the unique challenges of these disorders.
We provide comprehensive services in protocol development, endpoint selection, and regulatory submissions (FDA, EMA, global compliance), ensuring efficient trial execution and alignment with the highest scientific and regulatory standards.
With access to an extensive global network of clinical research sites and KOLs in musculoskeletal diseases, we enable rapid enrollment, retention, and high-quality data collection tailored to the needs of each trial.
In our clinical trials, NBCD leverages imaging techniques (X-ray, MRI), biomarkers, and advanced analytics to enhance recruitment, ensure trial precision, and selection of the right study population for the given treatment, providing more accurate insights into treatment effects.
From early-phase trials to large-scale studies, we ensure efficient project oversight, site management, data analysis, and pharmacovigilance, all aimed at driving successful regulatory submissions and patient-centered outcomes.
Trusted partner in musculoskeletal clinical research, delivering high-quality, science-led clinical trials
A proven track record in executing successful, data-driven studies across all clinical trial phases
Publishing numerous peer-reviewed articles every year that shape musculoskeletal clinical research – our trials utilize the latest knowledge in the field